-+ 0.00%
-+ 0.00%
-+ 0.00%

Elicio Therapeutics Reports Phase 2 Trial Shows ELI-002 7P Induces Broad Immune Response Beyond mKRAS

Reuters·12/11/2025 13:00:35

Please log in to view news